Marburg hemorrhagic fever has taken the lives of 11 people in Rwanda, according to health officials. This deadly virus shares similar symptoms with Ebola and has infected a total of 36 individuals. The first cases were found among patients in healthcare facilities. Although the outbreak was declared
Amidst a Marburg virus outbreak in Rwanda, vaccine testing is being fast-tracked. The cAd3-Marburg vaccine, developed by NIAID and tested in phase 1 trials last year, showed promising results with no severe adverse effects. However, its practical effectiveness remains untested. Phase 2 clinical tria
This weekend, Rwanda will receive experimental vaccines and therapeutics to fight the deadly Marburg virus. These will be used in clinical trials expected to start soon. The virus, similar to Ebola, has caused 41 cases so far, with 12 deaths, mostly among healthcare workers. The government aims to q
The recent outbreak of the Marburg virus in Rwanda has left healthcare workers and officials racing against time to contain its spread. With over 36 confirmed cases and 11 deaths reported, the situation is dire, but experts are optimistic that with swift action, the country can mitigate the crisis.
Rwanda is facing a deadly crisis as the Marburg virus continues to claim lives, leaving the country's health officials scrambling to contain the outbreak. With 36 confirmed cases and 11 deaths reported so far, the situation remains dire. The virus, which can have an 88% fatality rate, has already cl
Rwanda has never faced an outbreak of Marburg virus disease before, and with 18 people currently in treatment, eight fatalities, and over 100 contacts under surveillance, the nation is scrambling to contain this rare and deadly hemorrhagic disease. Unlike Ebola, there is no treatment or vaccine for
